Recently, news of insulin pump manufacturer Animas shutting its doors in North America spiraled into the community leaving insulin pump users with many more questions than answers. Some of the biggest questions surround what this means for patient choice in Canada, and how it will impact the pump market as Medtronic (who currently holds the largest market share in the Canada) becomes the only tubed insulin pump player in the country? What should pumpers whose pumps are out of warranty or type 1s interested in pump therapy for the first time keep their eyes on?
And let’s be real – The big question has been “When is Tandem coming to Canada?”
Although there is no availability date to share, we are so excited to let the community know that Tandem announced on October 26, 2017 that they have prioritized their efforts to make Canada the first country they will launch in outside of the United States in 2018.
If you’d heard about Tandem coming to Canada before today, you likely didn’t hear anything about timing. There was an announcement several weeks ago about plans to submit for Health Canada approval, but if you read through releases carefully, you’ll realize that there was never a mention about Canada being the next launch site. So now, it’s official!
We wanted to take a moment to share a bit more about Tandem and their products so you can know what to expect if you might be in the market for a new pump in the near future.
We also wanted to give you a chance to get information straight from Tandem when they do launch and to be kept in the loop about any info we might hear along the way from our friends in San Diego (where Tandem is based.) If you’re interested in opting in to the Tandem-specific mailings, let us know, below.
Here are the basics about the Tandem t:slim X2 pump
Disclaimer: Connected in Motion receives a grant through Tandem Diabetes Care to support our SoCal Slipstream weekend in California. We consider them one of our many partners, helping us to bring programming to life.